Search Within

Alexander Edward Drilon

  1. "Early Drug Development Service"
Formats
  1. Meeting Abstract (62)
  2. Journal Article (47)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (111)
  2. Early Drug Development Service (111)
  3. Solid Tumor Oncology Division (111)
  4. Thoracic Oncology (111)
  5. Department of Pathology and Laboratory Medicine (61)
  6. GSK Faculty (55)

More Groups

People
  1. David Hyman (78)
  2. Alison Schram (46)
  3. Marc Ladanyi (37)
  4. Jaclyn Hechtman (26)
  5. Ryma Benayed (25)
  6. Michael Berger (24)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (6)
  4. 2022 (8)
  5. 2021 (15)
  6. 2020 (18)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Annals of Oncology (15)
  3. Cancer Research (10)
  4. Clinical Cancer Research (8)
  5. Journal of Thoracic Oncology (7)
  6. Cancer Discovery (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (32)
  2. American Association for Cancer Research (25)
  3. Oxford University Press (16)
  4. Elsevier Inc. (9)
  5. Nature Publishing Group (8)
  6. Massachusetts Medical Society (3)

More Publishers

Results (111)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumors
    Meeting Abstract

    Doz, F.; Geoerger, B.; DuBois, S. G.; Grilley-Olson, J. E.; van Tilburg, C. M.; Italiano, A.; Lissat, A.; Kang, H. J.; Tahara, M.; Boni, V.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Activity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours
    Meeting Abstract

    Ziegler, D. S.; Doz, F.; Geoerger, B.; Dubois, S.; Grilley-Olson, J. E.; van Tilburg, C.; Italiano, A.; Lissat, A.; Kang, J. H.; Tahara, M.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Durability of response with larotrectinib in adult and pediatric patients with TRK fusion cancer
    Meeting Abstract

    Hyman, D.; Tan, D. S. W.; van Tilburg, C.; Albert, C.; Geoerger, B.; Farago, A.; Laetsch, T.; Kummar, S.; Doz, F.; Lassen, U.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Response to selective RET inhibition with LOXO-292 in a patient with RET fusion-positive lung cancer with leptomeningeal metastases
    Journal Article

    Guo, R.; Schreyer, M.; Chang, J. C.; Rothenberg, S. M.; Henry, D.; Cotzia, P.; Kris, M. G.; Rekhtman, N.; Young, R. J.; Hyman, D. M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Real-world outcomes of an automated physician support system for genome-driven oncology
    Journal Article

    Tao, J. J.; Eubank, M. H.; Schram, A. M.; Cangemi, N.; Pamer, E.; Rosen, E. Y.; Schultz, N.; Chakravarty, D.; Philip, J.; Hechtman, J. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
    Journal Article

    Durham, B. H.; Lopez Rodrigo, E.; Picarsic, J.; Abramson, D.; Rotemberg, V.; De Munck, S.; Pannecoucke, E.; Lu, S. X.; Pastore, A.; Yoshimi, A.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Molecular characteristics, immunophenotype, and immune checkpoint inhibitor response in BRAF non-V600 mutant lung cancers
    Meeting Abstract

    Offin, M.; Pak, T.; Mondaca, S.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Wu, S.; Kris, M.; Paik, P.; Riely, G.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Generation and characterization of novel preclinical disease models of NSCLC with NRG1 rearrangements to improve therapy
    Meeting Abstract

    Gladstone, E.; Vojnic, M.; Offin, M.; Delasos, L.; Lui, A.; Siau, E.; Sato, H.; Benayed, R.; Kurth, R.; Mattar, M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Activity of larotrectinib in TRK fusion lung cancer
    Meeting Abstract

    Farago, A.; Kummar, S.; Moreno, V.; Patel, J.; Lassen, U.; Rosen, L.; Ku, N.; Cox, M.; Nanda, S.; Childs, B.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Growth modulation index (GMI) as a comparative measure of clinical activity of larotrectinib versus prior systemic treatments in adult and pediatric TRK fusion cancer patients
    Meeting Abstract

    Italiano, A.; Nanda, S.; Keating, K.; Childs, B. H.; Fellous, M.; Drilon, A.; Hyman, D. M.
    Annals of Oncology (2019)

    Fulltext@MSK | Save